Elisabeth Sandoval Insider Trading $ALDR ALDER BIOPHARMACEUTICALS INC
Get free email notifications about insider trading for Elisabeth Sandoval.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Elisabeth Sandoval. Elisabeth Sandoval is in Intersect ENT, Inc. ($XENT) and CCO & EVP, Corporate Strategy in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Chief Commercial Officer in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Chief Commercial Officer in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and Chief Commerical Officer in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and Director in Menlo Therapeutics Inc. ($MNLO) and Director in Satsuma Pharmaceuticals, Inc. ($STSA).
Elisabeth Sandoval in ALDER BIOPHARMACEUTICALS INC
Trading Symbol: ALDRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Elisabeth Sandoval: CCO & EVP, Corporate Strategy, Chief Commercial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 21 2018
$ALDR Market Capitalization: $1.19B
$ALDR Previous Close: $23.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Elisabeth Sandoval in ALDER BIOPHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALDR, XENT, KYTH, STSA, MNLO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 21 2018 | ALDR | ALDER BIOPHARMACEU ... | Sandoval Elisabeth | CCO & EVP, Corporat ... | Option Exercise | A | 13.55 | 60,000 | 813,000 | 60,000 | |
Dec 21 2017 | ALDR | ALDER BIOPHARMACEU ... | Sandoval Elisabeth | Chief Commercial Of ... | Option Exercise | A | 10.95 | 150,000 | 1,642,500 | 150,000 | |
Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Sandoval Elisabeth | Chief Commercial Of ... | Option Exercise | A | 20.40 | 75,000 | 1,530,000 | 75,000 | |
Oct 07 2016 | ALDR | ALDER BIOPHARMACEU ... | Sandoval Elisabeth | Chief Commercial Of ... | Option Exercise | A | 31.47 | 225,000 | 7,080,750 | 225,000 |
Page: 1